<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Journal of Experimental and Clinical Surgery</journal-id><journal-title-group><journal-title xml:lang="en">Journal of Experimental and Clinical Surgery</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник экспериментальной и клинической хирургии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2070-478X</issn><issn publication-format="electronic">2409-143X</issn><publisher><publisher-name xml:lang="en">Voronezh State Medical University named after N.N. Burdenko</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">230</article-id><article-id pub-id-type="doi">10.18499/2070-478X-2013-6-4-432-438</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Unknown</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Opportunities of the Medicamental Correction of the Postcholecystectomy Disorders of the Microbiocenosis of the Colon at the Polyclinic Stage</article-title><trans-title-group xml:lang="ru"><trans-title>Возможности медикаментозной коррекции постхолецистэктомических нарушений микробиоценоза толстой кишки на поликлиническом этапе</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Глухов</surname><given-names>А.А.</given-names></name><bio xml:lang="en"><p>MD, Professor, Corresponding Member of the RANH, Head of the Department of General Surgery, Director of the Institute of Surgical Infection of Voronezh State Medical Academy named after N.N. Burdenko, Honored Inventor of the Russian Federation, Chairman of the Voronezh Branch of the Russian Society of Surgeons.</p></bio><bio xml:lang="ru"><p>.м.н., проф., зав. кафедрой общей хирургии, директор НИИ хирургической инфекции Воронежской государственной медицинской академии им. Н.Н. Бурденко</p></bio><email>surgery-v@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Кошелев</surname><given-names>П.И.</given-names></name><bio xml:lang="en"><p>MD, Professor of the Department of General Surgery of Voronezh State Medical Academy named after N.N. Burdenko, Honored Doctor of the Russian Federation.</p></bio><bio xml:lang="ru"><p>д.м.н., проф. кафедры общей хирургии Воронежской государственной медицинской академии им. Н.Н. Бурденко, заслуженный врач Российской Федерации</p></bio><email>author@vestnik-surgery.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Копылова</surname><given-names>Д.В.</given-names></name><bio xml:lang="en"><p>head of the surgery department, Voronezh outpatient hospital №4</p></bio><bio xml:lang="ru"><p>зав. хирургическим отдедением Воронежской городской клинической поликлиники №4</p></bio><email>dr_dasha@list.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N. Burdenko Voronezh State Medical Academy, 10 Studencheskaia Str., Voronezh, 394036, Russian Federation</institution></aff><aff><institution xml:lang="ru">Воронежская государственная медицинская академия им. Н.Н. Бурденко, Воронеж, Российская Федерация</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2013-12-24" publication-format="electronic"><day>24</day><month>12</month><year>2013</year></pub-date><volume>6</volume><issue>4</issue><issue-title xml:lang="ru"/><fpage>432</fpage><lpage>438</lpage><history><date date-type="received" iso-8601-date="2016-04-27"><day>27</day><month>04</month><year>2016</year></date><date date-type="accepted" iso-8601-date="2016-04-27"><day>27</day><month>04</month><year>2016</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2013, Voronezh N.N. Burdenko State Medical University</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2013, ФГБОУ ВО ВГМУ им. Н.Н. Бурденко Минздрава России</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="en">Voronezh N.N. Burdenko State Medical University</copyright-holder><copyright-holder xml:lang="ru">ФГБОУ ВО ВГМУ им. Н.Н. Бурденко Минздрава России</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://vestnik-surgery.com/journal/about/editorialPolicies</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnik-surgery.com/journal/article/view/230">https://vestnik-surgery.com/journal/article/view/230</self-uri><abstract xml:lang="en"><p>Relevance Laparoscopic cholecystectomy remains the leading treatment for gallstones. This article contains information about the state of the colonic microbiota after undergoing laparoscopic cholecystectomy. According to the literature, usually 96% of patients noted improvement in health in the first 30 days after surgery. Later, when they try to expand the diet, 37% of patients report disorders associated with the presence of intestinal dysbiosis. Materials and methods The study results are based on an analysis of the microbial status of the 179 patients receiving outpatient treatment at the outpatient hospital №4 during first 3 months after surgery. The trial showed that in the early period is characterized by a complete destabilization of the microbial balance in the colon. The correction of dysbiotic disorders with prebiotics, such as inulin and butyric acid is perspective. Results and their discussion The results of the study clearly indicated that the majority of patients in the early period after laparoscopic cholecystectomy observed clinical symptoms of colon such as flatulence (in 41.9% of cases), constipation - in 30.7% of cases, much less - diarrhea in 14.5% of patients. Alternating constipation and diarrhea was observed in 9.5% of patients. Conclusion Intestinal microbiota characterized by a total destabilization of the bacterial balance in 88.3% of patients with a prevalence of 2 degrees of dysbiosis. The use of butyric acid within 1 month after cholecystectomy helps to restore microbiota in 74.5% of patients and require further treatment. The use of drug-butyric acid for 3 months normobiotsenoza possible to achieve recovery of the colon in 91.5% of patients.</p></abstract><trans-abstract xml:lang="ru"><p>Актуальность Видеолапароскопическая холецистэктомия остается ведущим методом лечения желчнокаменной болезни. Статья содержит данные о состоянии толстокишечного микробиоценоза после перенесенной видеолапароскопической холецистэктомии. По данным литературы, обычно в первые 30 дней после операции 96% больных отмечают улучшение самочувствия. В дальнейшем, при попытке расширения диеты 37% пациентов отмечают постхолецистэктомические расстройства, связанные с наличием дисбактериоза кишечника. Цель исследования Изучить влияние препаратов масляной кислоты и инулина на микробиоценоз толстой кишки пациен- тов, перенесших видеолапароскопическую холецистэктомию в период амбулаторной реабилитации. Материалы и методы Исследование базируется на данных анализа микробного статуса толстой кишки 179 пациентов, получавших амбулаторное лечение в первые 3 месяца после оперативного лечения. Все пациенты были разделены на 2 группы. Первая, состоявшая из 59 человек, получала базисную корригирующую терапию в течение 1 месяца, включавшую ферментные препараты, спазмолитики, препараты урсодезоксихолевой кислоты и дополнительно получала препарат За- кофальк® NMX в дозировке по 1 таблетке 3 раза в день на протяжении 4 недель. При появлении запора дозировка пре- парата Закофальк® NMX снижалась до 1 таблетки 2 раза в день. Вторая группа, состоявшая из 120 пациентов, получала только базисную терапию. Результаты и их обсуждение У большинства больных в ранние сроки после видеолапароскопической холецистэктомии наблюдаются клинические симптомы поражения толстой кишки в виде метеоризма (в 41,9% случаев), запоров – у 30,7% больных, значительно реже – поносов (14,5% больных). Чередование запоров и поносов отмечено у 9,5% пациентов. Пер- спективными для коррекции дисбиотических нарушений оказались препараты из группы пребиотиков, такие как инулин и масляная кислота. Выводы Кишечный микробиоценоз раннего постстационарного периода после холецистэктомии характеризуется де- стабилизацией бактериального равновесия у 88,3% пациентов с преобладанием 2 степени дисбактериоза. Ранняя пост- стационарная реабилитация с использованием препарата масляной кислоты в течение 3 месяцев позволила добиться восстановления нормобиоценоза толстой кишки у 91,5% больных при хорошей переносимости и отсутствии побочных эффектов.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Laparoscopic cholecystectomy, inulin, butyric acid, dysbiosis, prebiotics</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>Лапароскопическая холецистэктомии, инулин, масляная кислота, дисбактериоз, пребиотиков</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1. Voronina O.V. Korrektsiia disbioza u bol'nykh posle</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>operatsii na organakh zheludochno-kishechnogo trakta</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>[Correction of dysbiosis in patients after operations on the</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>gastrointestinal tract]. Cand. Diss. (Med. Sci.). Moscow,</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>2009; 20. (In Russian)</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>2. Dadvani S.A. Zhelchnokamennaia bolezn' [Cholelithiasis].</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Moscow: GEOTAR-Media Publ., 2009; 175. (in Russ.).</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>3. Lazebnik L.B. Potrebnost' v medicinskoj pomoshchi posle operativnyh vmeshatel'stv na</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>zheludke i zhelchnom puzyre (obzor literatury i</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>nashi sobstvennye dannye [The need for medical care after surgery on</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>the stomach and gall bladder (review of the literature and</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>our own data)]. Ter.arkhiv. 2004; 2: 83–87. (in Russ.).</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>4. Malov V.A., Giulazian N.M. Mikrobiocenoza</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>zheludochno-kishechnogo trakta, sovremennoe sostoyanie problemy [Microbiocenosis of the</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>gastro-intestinal tract, the current status of the problem.]</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Lechashchii vrach. 2007; 66: [www.lvrach.ru]. (in Russ.).</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>5. Buianov V.M. Otdalennye rezul'taty laparoskopicheskoj</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>holecistehktomiya [Long-term results of laparoscopic</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>cholecystectomy.] Rossiiskii meditsinskii zhurnal. 1998; 1:</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>18-23. (in Russ.).</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>6. Merzlikin N.V. Otdalennye rezul'taty laparoskopicheskoj</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>holecistehktomii u pacientov Zapadno-Sibirskogo regiona. 5</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>S"s"ezd nauchnogo obshchestva gastroehnterologov Rossii [Long-term results of laparoscopic</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>cholecystectomy in patients of West Siberian region. 5</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>S"ezd nauchnogo obshchestva gastroenterologov Rossii]</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Proc. 5th Congress of Russian Scientific Society of</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Gastroenterologists. Moscow. 2005; 360-362. (in Russ.).</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>7. Skvortsova T.E. Kliniko-patogeneticheskie osobennosti</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>diagnostiki i lecheniia zhelchnokamennoi bolezni u bol'nykh</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>s narusheniem dvigatel'noi funktsii i mikrobiotsenoza</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>kishechnika [Clinical and pathogenetic features of the</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>diagnosis and treatment of cholelithiasis in patients with</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>impaired motor function and intestinal microbiocenosis].</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Cand. Diss. (Med. Sci.). St. Petersburg. 2007; 25. (in Russ.).</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>8. Sheviakov M.A. Korrekciya disbioza kishechnika:</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>sovremennye podhody. [The correction of intestinal dysbiosis:</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>modern approaches.] Lechashchii vrach. 2007; 6: [www.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>lvrach.ru]. (in Russ.).</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>9. Iakushev M.F. Funkcional'nyj status pacientov s</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>zhelchnokamennoj bolezn'yu, perenesshih ehndoskopicheskuyu</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>holecistehktomiya [Functional status of patients with</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>cholelithiasis who have transferred endoscopic</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>cholecystectomy.] Kazanskii meditsinskii zhurnal. 2008; 1:</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>37-41. (in Russ.).</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>10. Femia A.P. et al. Deyatel'nost' protivoopuholevye prebioticheskogo inulin, obogashchennyj oligofruktozoj v sochetanii s probiotikami rhamnosus Laktobacilly i Bifidobacteriumlactis na azoxymethane-inducirovannyj kancerogenez tolstoj kishki u krys [Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacteriumlactis on azoxymethane-induced colon carcinogenesis in rats.] Carcinogenesis. 2002; 23: 1953–1960.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>11. Butzner J.D., Parmar R, Bell C.J., Dalal V. Butirat klizmu</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>terapiya stimuliruet mukoznye remont v ehksperimental'nom kolite v</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>krysa [Butyrate enema therapy stimulates mucosal repair in experimental colitis in</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>rat.] Gut. 1996; 38: 568–573.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>12. Gibson G.R. Selektivnoj stimulyacii bifidobakterij v</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>tolstaya kishka cheloveka na oligofruktoza i inulin [Selective stimulation of bifidobacteria in the</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>human colon by oligofructose and inulin.] Gastroenterology.</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>1995; 10: 975–982.</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>13. KimY.I. Korotkocepochechnye zhirnye kisloty pri yazvennom kolite [Short-chain fatty acids in ulcerative colitis.]</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Nutrition Reviews. 1998; 56: 17–24.</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>14. Andoh A. et al. Fiziologicheskie i protivovospalitel'noe roli pishchevyh volokon i butirat kishechnoj funkcii. [Physiological and anti-inflammatory roles of dietary fiber and butyrate in intestinal fuctions.] J. Parenter Enteral Nutr. 1999; 23: 70–73.</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>15. Miller S.J. et al. Korotkocepochechnye zhirnye kisloty moduliruyut gen vyrazhenie dlya andotheial sosudistoj molekuly kletochnoj adgezii [Short-chain fatty acids modulate gene expression for vascular andotheial cell adhesion molecules.] Nutrition. 2005; 21: 740–748.</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>16. Mortensen P.B. et al. Korotkocepochechnyh zhirnyh kislot v chelovecheskom tolstoj kishki: svyaz' s zheludochno-kishechnogo zdorov'ya i bolezni [Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease.] Scand. J. Gastroenterol. Suppl. 1996; 216: 132–148.</mixed-citation></ref></ref-list></back></article>
